UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science

Go back to UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science

Raymond James on United Community Banks (UCB): 'we continue to view risk-reward as balanced'

April 21, 2026 3:46 PM EDT

Raymond James analyst Michael Rose reiterated a Market Perform rating on United Community Banks (NYSE: UCB).

The analyst comments "We are maintaining our Market Perform rating on shares of United Community Banks (UCB) following 1Q26 results that matched consensus... More